Kowa Snags Japan Rights to Nicox’s Eye Drop Asset for Glaucoma

February 8, 2024
French ophthalmology specialist Nicox said on February 8 that it is granting Kowa the exclusive Japanese rights to its nitric oxide-donating bimatoprost eye drop, NCX 470, being developed for the treatment of glaucoma and ocular hypertension. Under their license pact,...read more